ÂÜÀòÉç

In 1984 Dr. Basilion completed his BA in biochemistry at the University of Pennsylvania and entered the doctoral program at the Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston.  Following a post-doctoral fellowship at the National Institutes of Health (NICHD) and a short career in a Biotech startup, Dr. Basilion joined the Faculty of Harvard Medical School and MGH-Center for Molecular Imaging Research. In September 2005 Dr. Basilion joined the faculties of Medicine and Engineering at Case Western Reserve University. There he rose through the ranks and now is a full tenured professor in the Departments of Radiology and Biomedical Engineering and is currently Co-director of the Cancer Imaging Program for the Case Comprehensive Cancer Center. Previously he was the Vice-Chair for Basic Research at the Department of Radiology and the Director of the Case Center for Imaging Research. His research is translational in nature and he has founded two companies devoted to development of fluorescence image guided surgery for cancers. He has over 100 publications and over 50 issued/pending patents.

Angela Casini is Liesel Beckmann Distinguished Professor and Chair of Medicinal and Bioinorganic Chemistry, as well as ad interim Chair of Pharmaceutical Radiochemistry, at the Technical University of Munich (TUM, Germany). Angela completed her PhD in Chemistry at the University of Florence (Italy) in 2004, and, afterwards, moved to EPFL (Switzerland) as principal investigator funded by the Swiss National Science Foundation. Between 2011-2019, she was assistant professor at the University of Groningen (The Netherlands) and Chair at Cardiff University (UK). She is recipient of many awards and has authored more than 280 publications with a H-index of 77. Since 2023, she is member of the European Academy of Sciences.

Jason Davis is a Professor of Chemistry at Oxford & Senior Tutor in Chemistry at Christ Church. His group have published almost 200 research papers (averaging almost 50 citations per paper) in leading journals. His research interests are broad and primarily focussed on the design and utilisation of functional Interfaces, particularly those associated with molecular recognition and switching. This has included the design and generation of a broad range of responsive nanoparticulate systems, tools whereby supramolecular ion binding can be tracked by capacitance, modulated by local redox switches, surface polarisations or local dielectric. His team have invented new ways of transducing (macro)molecular recognition; open circuit potential methods, shotgun methods, rapid kinetic quantification, magnetic field promoted target capture, and the use of antigen mimick nanoparticles to capture cancer antibodies. Davis is the founder of Osler Diagnostics, a company that has now raised more than £150 million and employs close to 150 people. He was born in London, and lives in rural Oxfordshire with his wife, daughter and direwolves.

Maryellen Giger, Ph.D. is the A.N. Pritzker Distinguished Service Professor of Radiology, Committee on Medical Physics, and the College at the University of Chicago.  Her AI research in cancer, neuro-imaging, COVID-19, and other diseases for risk assessment, diagnosis, prognosis, and therapeutic response has yielded various translated components, including “virtual biopsies”. She is contact PI for the Medical Imaging and Data Resource Center (MIDRC; midrc.org).  Giger has more than 290 peer-reviewed publications; more than 30 patents, and has mentored over 200 trainees. Giger is former president of AAPM and of SPIE; member of the National Academy of Engineering, recipient of the AAPM Gold Medal, SPIE Barrett Award in Medical Imaging, RSNA’s Outstanding Researcher Award, and Fellow of AAPM, AIMBE, SPIE, and IEEE. 

Tony D James is a Professor at the University of Bath and Fellow of the ÂÜÀòÉç. He has developed a broad interdisciplinary approach to research, with an underpinning focus on the development of modular sensors, where he has pioneered a range of reporting regimes. His research interests include many aspects of supramolecular chemistry, including molecular recognition, fluorescent sensor design, fluorescence imaging, chiral recognition, saccharide recognition, anion recognition, probes for redox imbalance and theranostic systems. He received his BSc from the University of East Anglia (1986), PhD from the University of Victoria (1991), and was a Postdoctoral Research Fellow in Japan with Seiji Shinkai (1992-95). He was awarded a Royal Society University Research Fellowship at the University of Birmingham (1995-2000) before moving to the University of Bath in 2000. He was a Royal Society Wolfson Research Merit Award holder from 2017 to 2022. He has published over 500 publications in international peer reviewed journals, h-index of 96 and is listed by Clarivate as a Highly Cited Researcher since 2022.

Kazuya Kikuchi FRSC obtained his Ph.D. from the university of Tokyo in 1994, then, a postdoctoral fellow with Prof. Roger Y. Tsien UCSD. Subsequently, he moved to Prof. Donald Hilvert laboratory at the Scripps research Institute. He returned Japan as a research associate at the university of Tokyo in 1997, and promoted to an associate professor in 2000. He moved to Osaka University as a professor in 2005, currently a distinguished professor. During this period he became involved in molecular imaging probes development for both fluorescence and magnetic resonance imaging. He is focused both in in vivo imaging and single molecule cellular imaging.